Retained Products After Miscarriage

DBCOND0136568Disease and Non-Disease Concepts, UnclassifiedPregnancy, Puerperium, and Perinatal Conditions

Retained Products After Miscarriage is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.

Also known as
Abortion, Incomplete · Abortion incomplete · Incomplete Abortion · Incomplete Miscarriage · Miscarriage, Incomplete
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0000033SNOMED CT156071003MedDRA10000217UMLSC0000810

What you can answer from here — as of October 23, 2026

2Indicated drugsWith each drug's targets and mechanism
Listed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
26Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Drug reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Retained Products After Miscarriage share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In